FDA will probably never get any credit for being the fastest-responding of all federal agencies, and the announcement yesterday that it will reclassify some coronary artery catheters from class III to class II did nothing to dispel doubts about the agency's responsiveness to advisory panel recommendations. (Medical Device Daily) Read More
